See more : HUTCHMED (China) Limited (HMDCF) Income Statement Analysis – Financial Results
Complete financial analysis of China Life Insurance Company Limited (LFC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Life Insurance Company Limited, a leading company in the Insurance – Life industry within the Financial Services sector.
You may be interested
- Elekta AB (publ) (EKTA-B.ST) Income Statement Analysis – Financial Results
- Winshine Science Company Limited (0209.HK) Income Statement Analysis – Financial Results
- ADVFN Plc (AFN.L) Income Statement Analysis – Financial Results
- D.R. Horton, Inc. (0I6K.L) Income Statement Analysis – Financial Results
- Kingswood Holdings Limited (KWG.L) Income Statement Analysis – Financial Results
China Life Insurance Company Limited (LFC)
About China Life Insurance Company Limited
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates in four segments: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses. It offers critical illness protection, annuity, children/women/pension, security, life, medical, and accident protection insurance products. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited is a subsidiary of China Life Insurance (Group) Company Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 734.85B | 803.98B | 824.53B | 804.96B | 729.47B | 627.42B | 643.36B | 540.78B | 507.45B | 440.77B | 417.88B | 371.49B | 370.90B | 385.84B | 339.29B | 166.81B | 191.37B | 147.31B | 98.21B | 76.81B | 78.88B | 74.31B | 61.21B |
| Cost of Revenue | -94.41B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 829.26B | 803.98B | 824.53B | 804.96B | 729.47B | 627.42B | 643.36B | 540.78B | 507.45B | 440.77B | 417.88B | 371.49B | 370.90B | 385.84B | 339.29B | 166.81B | 191.37B | 147.31B | 98.21B | 76.81B | 78.88B | 74.31B | 61.21B |
| Gross Profit Ratio | 112.85% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 41.08B | 39.87B | 40.81B | 37.69B | 40.28B | 37.49B | 35.95B | 31.85B | 27.46B | 25.43B | 24.81B | 23.28B | 0.00 | 20.29B | 18.72B | 12.11B | 11.80B | 9.34B | 7.24B | 6.59B | 6.86B | 0.00 | 0.00 |
| Selling & Marketing | -949.00M | 2.89B | 2.92B | 2.67B | 3.23B | 3.08B | 3.23B | 2.83B | 2.51B | 2.47B | 2.68B | 3.01B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 40.13B | 39.87B | 40.81B | 37.69B | 40.28B | 37.49B | 35.95B | 31.85B | 27.46B | 25.43B | 24.81B | 23.28B | 21.55B | 20.29B | 18.72B | 12.11B | 11.80B | 9.34B | 7.24B | 6.59B | 6.86B | 0.00 | 5.10B |
| Other Expenses | 682.48B | -816.37B | -826.34B | -798.59B | -718.88B | -647.41B | -637.64B | -548.79B | -488.98B | -425.80B | -416.36B | -383.80B | -371.22B | -366.89B | -316.97B | -156.35B | -158.19B | -131.05B | -93.94B | -73.89B | -86.01B | -77.82B | -71.02B |
| Operating Expenses | 722.61B | -776.50B | -785.53B | -760.91B | -678.60B | -609.92B | -601.68B | -516.94B | -461.52B | -400.36B | -391.56B | -360.52B | -349.67B | -346.60B | -298.25B | -144.24B | -146.39B | -121.71B | -86.70B | -67.30B | -79.15B | -77.82B | -65.92B |
| Cost & Expenses | 722.61B | 779.93B | 774.03B | 750.47B | 669.68B | 613.50B | 601.68B | 516.94B | 461.52B | 400.36B | 388.43B | 360.52B | 350.39B | 344.83B | 297.55B | 144.01B | 145.98B | 121.71B | 86.70B | 67.30B | 79.15B | 1.66B | 7.28B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.35B | 0.00 | 6.74B | 3.97B | 0.00 | 0.00 |
| Interest Expense | 0.00 | 4.86B | 5.60B | 3.75B | 4.26B | 4.12B | 4.60B | 4.77B | 4.32B | 4.73B | 4.03B | 2.58B | 873.00M | 27.26B | 0.00 | 0.00 | 0.00 | 1.00B | 705.00M | 4.32B | 1.00M | 0.00 | 0.00 |
| Depreciation & Amortization | 4.76B | 5.29B | 4.88B | 4.75B | 4.38B | 2.45B | 2.18B | 2.04B | 2.04B | 2.12B | 2.03B | 1.95B | 1.91B | 1.80B | 1.56B | 1.35B | 14.53B | 11.17B | 8.71B | 6.92B | 6.31B | 0.00 | 0.00 |
| EBITDA | 0.00 | 55.66B | 75.26B | 50.89B | 55.25B | 24.19B | 48.96B | 29.93B | 51.42B | 46.63B | 35.46B | 15.83B | 24.33B | 44.12B | 45.47B | 24.50B | 37.06B | 27.51B | 26.09B | 13.82B | 7.28B | -3.51B | -4.71B |
| EBITDA Ratio | 0.00% | 4.08% | 5.37% | 6.11% | 7.57% | 3.21% | 7.46% | 5.59% | 10.21% | 10.65% | 8.44% | 4.11% | 6.24% | 11.05% | 12.72% | 14.40% | 31.31% | 24.96% | 20.59% | 21.32% | 7.68% | -4.72% | -7.69% |
| Operating Income | 12.24B | 27.48B | 39.00B | 44.06B | 50.87B | 17.50B | 41.67B | 23.84B | 45.93B | 40.40B | 26.33B | 10.97B | 21.23B | 39.24B | 41.04B | 22.58B | 44.98B | 25.61B | 11.51B | 9.50B | -263.00M | -3.51B | -4.71B |
| Operating Income Ratio | 1.67% | 3.42% | 4.73% | 5.47% | 6.97% | 2.79% | 6.48% | 4.41% | 9.05% | 9.17% | 6.30% | 2.95% | 5.72% | 10.17% | 12.10% | 13.53% | 23.51% | 17.38% | 11.72% | 12.37% | -0.33% | -4.72% | -7.69% |
| Total Other Income/Expenses | -363.00M | -336.00M | -41.24B | -8.76B | -195.00M | -16.49B | -211.00M | -245.00M | -82.00M | 149.00M | 548.00M | -342.00M | -17.62B | -5.17B | 0.00 | -2.62B | -5.58B | -996.00M | -11.62B | -6.35B | 1.23B | -2.00M | 6.00M |
| Income Before Tax | 11.88B | 24.05B | 50.50B | 54.49B | 59.80B | 13.92B | 41.67B | 23.84B | 45.93B | 40.40B | 29.45B | 10.97B | 20.51B | 41.01B | 41.75B | 22.80B | 45.39B | 25.61B | 11.51B | 9.50B | -263.00M | -3.51B | -4.70B |
| Income Before Tax Ratio | 1.62% | 2.99% | 6.12% | 6.77% | 8.20% | 2.22% | 6.48% | 4.41% | 9.05% | 9.17% | 7.05% | 2.95% | 5.53% | 10.63% | 12.30% | 13.67% | 23.72% | 17.38% | 11.72% | 12.37% | -0.33% | -4.72% | -7.68% |
| Income Tax Expense | -10.76B | -9.47B | -1.92B | 3.10B | 781.00M | 1.99B | 8.92B | 4.26B | 10.74B | 7.89B | 4.44B | -304.00M | 2.02B | 7.20B | 8.71B | 1.39B | 6.33B | 5.55B | 2.15B | 2.28B | 1.18B | 14.00M | 4.00M |
| Net Income | 21.11B | 32.08B | 50.77B | 50.26B | 58.29B | 11.40B | 32.25B | 19.13B | 34.70B | 32.21B | 24.77B | 11.06B | 18.33B | 33.63B | 32.88B | 21.28B | 39.06B | 20.05B | 9.37B | 7.17B | -1.43B | -3.52B | -4.71B |
| Net Income Ratio | 2.87% | 3.99% | 6.16% | 6.24% | 7.99% | 1.82% | 5.01% | 3.54% | 6.84% | 7.31% | 5.93% | 2.98% | 4.94% | 8.72% | 9.69% | 12.76% | 20.41% | 13.61% | 9.54% | 9.34% | -1.81% | -4.74% | -7.70% |
| EPS | 0.75 | 1.14 | 1.80 | 1.78 | 2.05 | 0.40 | 1.13 | 0.66 | 1.22 | 1.14 | 0.88 | 0.39 | 0.65 | 1.19 | 1.16 | 0.68 | 1.38 | 0.75 | 0.35 | 0.10 | -0.07 | -0.18 | -0.09 |
| EPS Diluted | 0.75 | 1.14 | 1.80 | 1.78 | 2.05 | 0.40 | 1.13 | 0.66 | 1.22 | 1.14 | 0.88 | 0.39 | 0.65 | 1.19 | 1.16 | 0.68 | 1.38 | 0.75 | 0.35 | 0.10 | -0.07 | -0.18 | -0.09 |
| Weighted Avg Shares Out | 28.15B | 28.27B | 28.27B | 28.27B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 26.61B | 26.58B | 70.82B | 20.48B | 19.58B | 52.29B |
| Weighted Avg Shares Out (Dil) | 28.27B | 28.27B | 28.27B | 28.27B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 26.61B | 26.58B | 70.82B | 20.48B | 19.58B | 52.29B |
China Life Insurance Company Limited Announces 2021 Interim Results (H Shares)
HONG KONG, Aug. 25, 2021 /PRNewswire/ -- China Life Insurance Company Limited (SSE: 601628, SEHK: 2628, NYSE: LFC) announces the unaudited consolidated results of the Company (China Life Insurance Company Limited and its subsidiaries) for the six months ended 30 June...
7 Best Blue-Chip Stocks Under $20 for Your Buy List
These blue-chip stocks are trading at a low valuation but are set for sizeable gains this year as the global opens up again The post 7 Best Blue-Chip Stocks Under $20 for Your Buy List appeared first on InvestorPlace. More...
Insurance Stock Gainers And Losers In Tuesdays Premarket Session
Here are the insurance stocks that are moving in Tuesday's premarket session on the stock market . Gainers Lincoln National Corp (NYSE: LNC) stock fell by 0.35% to $64.78 during Monday's trading session.
China Life Insurance: Our Top Financial Pick For The Rest Of 2021
China Life Insurance: Our Top Financial Pick For The Rest Of 2021
Is China Life (LFC) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
Are Investors Undervaluing China Life (LFC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
China Life's Successful Turnaround To Drive Its Future Valuation Uptick
Chinese life insurance sector offers an attractive investment opportunity for long-term investors given its massive and ageing population and low life insurance penetration rate. China Life launched restructuring initiatives in 2018 and is showing encouraging results that have largely been...
Should Value Investors Buy China Life (LFC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
China Life Insurance: The Former Champion's Anxiety
China Life Insurance will remain on the top of the Chinese insurance market - in the short term. Its leading position has been challenged by fintech disruptors.
A Trio of Stocks Trading Below Intrinsic Value
Value-oriented investors may want to consider the following securities since their shares are trading at a discount to the intrinsic value calculated by GuruFocus' earnings-based discounted cash flow calculator.
Source: https://incomestatements.info
Category: Stock Reports